Research & Innovation
Publications

From natalizumab to fingolimod in eight weeks - Immunological, clinical, and radiological data in quest of the optimal switch.

#2017

#CLINICAL IMMUNOLOGY

PMU Authors
Andrea Harrer, Georg Pilz, Katrin Oppermann, Elisabeth Haschke-Becher, Mark R. McCoy, Wolfgang Hitzl, Eugen Trinka, Jörg Kraus, Johann Sellner, Peter Wipfler

All Authors
Andrea Harrer, Georg Pilz, Katrin Oppermann, Marlene Sageder, Shahrzad Afazel, Elisabeth Haschke-Becher, Theo Rispens, Annick de Vries, Mark R. McCoy, Vlado Stevanovic, Wolfgang Hitzl, Eugen Trinka, Jörg Kraus, Johann Sellner, Peter Wipfler

Journal association
CLINICAL IMMUNOLOGY

Abstract

Keywords

PLACEBO-CONTROLLED TRIAL, EFFICACY, ORAL FINGOLIMOD, FTY720, RELAPSING MULTIPLE-SCLEROSIS, DISEASE-ACTIVITY, IMMUNE, TIME, SATURATION, WITHDRAWAL

Latest Publication

#2025

#Abstract

Valentin Fischill-Neudeck, Antje van der Zee-Neuen, Margitta B. Beil-Hildebrand Strengthening Professional Health Literacy: A Theory-Based Approach to Empower Nursing Practice

#2025

#Original Article

Margaux Delporte, Johan Verbeeck, Isabella Brambilla, Georg Zimmermann, Geert Molenberghs, Rima Nabbout, Dravet syndrome, REGISTRY; RARE DISEASES; DRAVET SYNDROME; Natural history;

#2025

#Editorial

Eunkyeong Oh, Alberto Lucchini, Peter Nydahl Personalized approaches to ICU Distress

Back to Overview

Paracelsus Medical University (PMU) Research & Innovation Publications

From natalizumab to fingolimod in eight weeks -...